111 related articles for article (PubMed ID: 38451282)
1. Cardenolide glycosides sensitize gefitinib-induced apoptosis in non-small cell lung cancer: inhibition of Na
Du CM; Leu WJ; Jiang YH; Chan SH; Chen IS; Chang HS; Hsu LC; Hsu JL; Guh JH
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; ():. PubMed ID: 38451282
[TBL] [Abstract][Full Text] [Related]
2. Epi-reevesioside F inhibits Na+/K+-ATPase, causing cytosolic acidification, Bak activation and apoptosis in glioblastoma.
Hsu JL; Liu FL; Hsu LC; Chang HS; Leu WJ; Yu CC; Chang WL; Chen IS; Kung FL; Guh JH
Oncotarget; 2015 Sep; 6(27):24032-46. PubMed ID: 26125228
[TBL] [Abstract][Full Text] [Related]
3. Reevesioside F induces potent and efficient anti-proliferative and apoptotic activities through Na⁺/K⁺-ATPase α3 subunit-involved mitochondrial stress and amplification of caspase cascades.
Chan SH; Leu WJ; Hsu LC; Chang HS; Hwang TL; Chen IS; Chen CS; Guh JH
Biochem Pharmacol; 2013 Dec; 86(11):1564-75. PubMed ID: 24099795
[TBL] [Abstract][Full Text] [Related]
4. Ascleposide, a natural cardenolide, induces anticancer signaling in human castration-resistant prostatic cancer through Na
Leu WJ; Wang CT; Hsu JL; Chen IS; Chang HS; Guh JH
Prostate; 2020 Mar; 80(4):305-318. PubMed ID: 31905252
[TBL] [Abstract][Full Text] [Related]
5. Reevesioside A, a cardenolide glycoside, induces anticancer activity against human hormone-refractory prostate cancers through suppression of c-myc expression and induction of G1 arrest of the cell cycle.
Leu WJ; Chang HS; Chan SH; Hsu JL; Yu CC; Hsu LC; Chen IS; Guh JH
PLoS One; 2014; 9(1):e87323. PubMed ID: 24475272
[TBL] [Abstract][Full Text] [Related]
6. The Cardenolide Glycoside Acovenoside A Interferes with Epidermal Growth Factor Receptor Trafficking in Non-Small Cell Lung Cancer Cells.
Hafner S; Schmiech M; Lang SJ
Front Pharmacol; 2021; 12():611657. PubMed ID: 34025398
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic cardenolide glycosides from the root of Reevesia formosana.
Chang HS; Chiang MY; Hsu HY; Yang CW; Lin CH; Lee SJ; Chen IS
Phytochemistry; 2013 Mar; 87():86-95. PubMed ID: 23313131
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of AMANTADIG - a semisynthetic digitoxigenin derivative - alone and in combination with docetaxel in human hormone-refractory prostate cancer cells and its effect on Na
Silva IT; Munkert J; Nolte E; Schneider NFZ; Rocha SC; Ramos ACP; Kreis W; Braga FC; de Pádua RM; Taranto AG; Cortes V; Barbosa LA; Wach S; Taubert H; Simões CMO
Biomed Pharmacother; 2018 Nov; 107():464-474. PubMed ID: 30107342
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of glucoevatromonoside alone and in combination with chemotherapy drugs and their effects on Na
Schneider NFZ; Menegaz D; Dagostin ALA; Persich L; Rocha SC; Ramos ACP; Cortes VF; Fontes CFL; de Pádua RM; Munkert J; Kreis W; Braga FC; Barbosa LA; Silva FRMB; Simões CMO
Mol Cell Biochem; 2021 Apr; 476(4):1825-1848. PubMed ID: 33459980
[TBL] [Abstract][Full Text] [Related]
10. The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines.
Shen L; Li Z; Shen S; Niu X; Yu Y; Li Z; Liao M; Chen Z; Lu S
Lung Cancer; 2012 Dec; 78(3):193-200. PubMed ID: 22985911
[TBL] [Abstract][Full Text] [Related]
11. Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations.
Park IH; Kim JY; Jung JI; Han JY
Invest New Drugs; 2010 Dec; 28(6):791-9. PubMed ID: 19760159
[TBL] [Abstract][Full Text] [Related]
12. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling.
Wang LH; Li Y; Yang SN; Wang FY; Hou Y; Cui W; Chen K; Cao Q; Wang S; Zhang TY; Wang ZZ; Xiao W; Yang JY; Wu CF
Br J Cancer; 2014 Jan; 110(2):341-52. PubMed ID: 24300974
[TBL] [Abstract][Full Text] [Related]
13. [Mechanism of n-butanol fraction of Wenxia Formula combining with gefitinib in treating non-small cell lung cancer based on network pharmacology and in vitro experiment].
Chen RJ; Bi QY; Shi JM; Zhong J; Han JT; Ji XM
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):471-486. PubMed ID: 38403323
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic and cytostatic effects of digitoxigenin monodigitoxoside (DGX) in human lung cancer cells and its link to Na,K-ATPase.
Schneider NFZ; Persich L; Rocha SC; Ramos ACP; Cortes VF; Silva IT; Munkert J; Pádua RM; Kreis W; Taranto AG; Barbosa LA; Braga FC; Simões CMO
Biomed Pharmacother; 2018 Jan; 97():684-696. PubMed ID: 29101813
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of gefitinib and thalidomide treatment on EGFR-TKI-sensitive and -resistant NSCLC.
Xia X; Liu Y; Liao Y; Guo Z; Huang C; Zhang F; Jiang L; Wang X; Liu J; Huang H
Eur J Pharmacol; 2019 Aug; 856():172409. PubMed ID: 31132355
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation.
Zou M; Xia S; Zhuang L; Han N; Chu Q; Chao T; Peng P; Chen Y; Gui Q; Yu S
Int J Oncol; 2013 Jun; 42(6):2094-102. PubMed ID: 23588221
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Novel Agents on Spindle Assembly Checkpoint to Sensitize Vinorelbine-Induced Mitotic Cell Death Against Human Non-Small Cell Lung Cancers.
Chang YC; Tseng YL; Leu WJ; Du CM; Jiang YH; Hsu LC; Hsu JL; Hou DR; Guh JH
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764382
[TBL] [Abstract][Full Text] [Related]
18. Everolimus synergizes with gefitinib in non-small-cell lung cancer cell lines resistant to epidermal growth factor receptor tyrosine kinase inhibitors.
Dong S; Zhang XC; Cheng H; Zhu JQ; Chen ZH; Zhang YF; Xie Z; Wu YL
Cancer Chemother Pharmacol; 2012 Nov; 70(5):707-16. PubMed ID: 22941374
[TBL] [Abstract][Full Text] [Related]
19. Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated.
Park SY; Kim YM; Pyo H
Mol Cancer; 2010 Aug; 9():222. PubMed ID: 20731837
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic effects of the cardenolide convallatoxin and its Na,K-ATPase regulation.
Schneider NFZ; Silva IT; Persich L; de Carvalho A; Rocha SC; Marostica L; Ramos ACP; Taranto AG; Pádua RM; Kreis W; Barbosa LA; Braga FC; Simões CMO
Mol Cell Biochem; 2017 Apr; 428(1-2):23-39. PubMed ID: 28176244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
